1-3 of 3
Thynn Thynn Yee
Close
Sort by
Journal Articles

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

Clinical Trials & Observations
Pier Mannuccio Mannucci, Christine Kempton, Carolyn Millar, Edward Romond, Amy Shapiro, Ingvild Birschmann, Margaret V. Ragni, Joan Cox Gill, Thynn Thynn Yee, Robert Klamroth, Wing-Yen Wong, Miranda Chapman, Werner Engl, Peter L. Turecek, Tobias M. Suiter, Bruce M. Ewenstein
Journal: Blood
Blood (2013) 122 (5): 648–657.
https://doi.org/10.1182/blood-2013-01-479527
Published: 2013
Includes: Supplemental data
Journal Articles

Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease

Tobias M Suiter, MD, Pier Mannuccio Mannucci, MD, Christine L Kempton, MD, MSc, Michael Laffan, MD, Edward H Romond, MD, Amy D. Shapiro, MD, Ingvild Birschmann, MD, PhD, Margaret V. Ragni, MD, MPH, Joan Cox Gill, MD, Thynn Thynn Yee, MD, MSc, FRCP, Robert Klamroth, MD, PhD, Frank M Horling, PhD, Birgit M Reipert, PhD, Peter L Turecek, PhD, Katalin Varadi, PhD, Miranda Chapman, Werner Engl, PhD, Wing Yen Wong, MD, Bruce M. Ewenstein, MD PhD, rhVWF Study Team
Journal: Blood
Blood (2011) 118 (21): 2275.
https://doi.org/10.1182/blood.V118.21.2275.2275
Published: 2011
Journal Articles

Two classes of germline genes both derived from the V H 1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII

Edward N. van den Brink, Wendy S. Bril, Ellen A. M. Turenhout, Marleen Zuurveld, Niels Bovenschen, Marjolein Peters, Thynn Thynn Yee, Koen Mertens, Deborah A. Lewis, Thomas L. Ortel, Pete Lollar, Dorothea Scandella, Jan Voorberg
Journal: Blood
Blood (2002) 99 (8): 2828–2834.
https://doi.org/10.1182/blood.V99.8.2828
Published: 2002